Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort. The research took place at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). Two studies, published in the journal iOncoImmunology/i, identify new peptide vaccines and inhibitors that target the HER-3 and IGF-1R receptors. All ...Thursday, 25 September 2014
Researchers Develop New Anti-Cancer Peptide Vaccines and Inhibitors
Researchers have developed two new anticancer peptide vaccines and two peptide inhibitors as part of a larger peptide immunotherapy effort. The research took place at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). Two studies, published in the journal iOncoImmunology/i, identify new peptide vaccines and inhibitors that target the HER-3 and IGF-1R receptors. All ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment